Merck plans to acquire Prometheus for $10.8 billion in an all-cash deal. The deal will add Prometheus' lead candidate, immunology drug PRA023, to Merck's pipeline. The magnitude of Prometheus' massive ...

US startups raised $20.80 billion across 442 deals in April 2026, up 63.9% in capital and 21.1% in deal count from April 2025 ...

Global venture funding reached $56 billion in April, marking the third-largest monthly funding in a year. Funding was up 100% ...

A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Bezos’s hush‑hush AI project is lining up massive funding and targeting real‑world uses.

Project Prometheus is raising around $10 billion in fresh funding at a post-money valuation of around $38 billion.

The acquisition adds strategic procurement, group purchasing, and supply chain optimization capabilities to the ...